← Open Payments lookup

CRAIG PANNELL: Open Payments

NPI 1013925460 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,018 in 64 payments from 10 companies in 2025. Trend: 2023 $988 · 2024 $701 · 2025 $1,018

Food & beverage: $835Education: $183
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.7$254
E.R. Squibb & Sons, L.L.C.27$238
ABBVIE INC.11$137
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$122
Neurocrine BioSciences, Inc.3$78
Vanda Pharmaceuticals Inc.3$65
Janssen Pharmaceuticals, Inc3$56
Otsuka America Pharmaceutical, Inc.2$36
Alkermes, Inc.1$18
Axsome Therapeutics, Inc.1$14

Products named: COBENFY, VRAYLAR, CAPLYTA, INGREZZA, FANAPT, INVEGA SUSTENNA, UZEDY, AUSTEDO XR.

Industry payments across TX — which companies pay providers there.